Bulgaria: Huvepharma decides against Amsterdam IPO to stay private – for now

Kiril Domushiev, president and CEO of Huvepharma

Huvepharma Group, the Bulgaria headquartered livestock animal health company with strong positions in the veterinary and feed additives segments, has announced that it and its sole shareholder, fellow Bulgarian company Advance Properties, have decided to stop its proposed IPO on Euronext Amsterdam. Earlier in June, the company had announced plans to raise €300m (US$355.4m) via…

You must be a HMI Subscriber to view this content.

Subscribe Now »